OakChart

ASP Isotopes Inc

ASPIBasic Materials·Specialty Chemicals·USA·Small·NASD·Nov 11 • 8:34 AM ET

2.06+0.08 (4.12%)
2026-11-11 14:39 CET
Market cap
303.55 USD m
Revenue, TTM
30.85 USD m
Net income, TTM
-132.05 USD m
Free cash flow, TTM
-83.58 USD m
EPS diluted, TTM
-1.32
P/E
-
Compare

Price

ASPI against its 20, 50 and 200-day averages
2050200earnings
2.004.006.008.007.0M14.0MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ASPIclose 2.0620-day 2.0350-day 2.66200-day 4.622.06

81.4% under 11.09 on 30 Oct 2025. Last 15 sessions, 32.5% high to low

Profile

ASPI
52-week range, 5% of the way up
1.669.24

ASP Isotopes, Inc. is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. It operates through the following segments: Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment engages in the research and development of technologies and methods for producing HALEU and Lithium-6 for the advanced nuclear fuels target market, including the operations of QLE. The Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods for the separation of high-value, low-volume isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

IndexRUT
Employees271
IPONov 10, 2022
Beta3.78
ATR, 14d0.21
Rel volume0.12
Short float22.93%
Insider own10.74%
Inst own46.51%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap316.04M
Enterprise Value336.66M
Income-132.05M
Sales30.85M
Book/sh2.03
Cash/sh1.69
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees271
IPONov 10, 2022

Ratios

P/E-
Forward P/E-
PEG-
P/S10.24
P/B1.01
P/C1.22
P/FCF-
EV/EBITDA-
EV/Sales10.91
Quick Ratio3.84
Current Ratio3.86
Debt/Eq1.02
LT Debt/Eq0.81
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.32
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y-148.35% -129.60%
Sales past 3/5Y- -
EPS Y/Y TTM5.80%
Sales Y/Y TTM573.40%
EPS Q/Q73.38%
Sales Q/Q327.51%
EarningsJun 03
EPS/Sales Surpr.-690.00% 720.67%

Ownership

Insider Own10.74%
Insider Trans-4.87%
Inst Own46.51%
Inst Trans-1.44%
ROA-42.84%
ROE-104.60%
ROIC-27.59%
Gross Margin-0.49%
Oper. Margin-312.31%
Profit Margin-428.00%
SMA201.71%
SMA50-22.47%
SMA200-55.42%
Trades-

Technical

Shs Outstand153.31M
Shs Float136.84M
Short Float22.93%
Short Ratio7.61
Short Interest31.37M
52W High9.24 -77.69%
52W Low1.66 24.19%
Volatility12.49% 9.51%
ATR (14)0.21
RSI (14)44.82
Beta3.78
Rel Volume0.12
Avg Volume4.12M
Volume25,652

Performance

Perf Week7.93%
Perf Month-9.58%
Perf Quarter-51.83%
Perf Half Y-67.38%
Perf YTD-61.47%
Perf Year-76.39%
Perf 3Y44.16%
Perf 5Y-
Perf 10Y-
Recom1.00
Target Price13.00
Prev Close1.98
Price2.06
Change %4.12%

Analyst ratings

latest 3 of 3
DateActionAnalystRating changeTargetImplied
Dec 04, 2025InitiatedCCantor FitzgeraldOverweight$13+530.6%
Oct 04, 2024InitiatedCCanaccord GenuityBuy$4.50+118.3%
Dec 05, 2023InitiatedHH.C. WainwrightBuy$3.25+57.7%

Peers

Mkt cap
TickerCompanyMkt cap
STDNStandard Nuclear Inc2.02B
LEUCentrus Energy Corp2.35B
BWXTBWX Technologies Inc11.83B
LTBRLightbridge Corp182.19M
NNENano Nuclear Energy Inc660.48M
CATXPerspective Therapeutics Inc94.95M
LNTHLantheus Holdings Inc6.64B
OKLOOklo Inc5.25B
CCJCameco Corp32.73B
TLXTelix Pharmaceuticals Ltd ADR3.22B

Insider trading

latest 14 of 52
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Kiessling HeatherChief Financial OfficerOct 16 '26Sale2.1921,83047,8081,504,422Oct 21 09:45 PM
Ainscow RobertCOOOct 14 '26Sale2.1122,50047,5652,225,941Oct 16 09:57 PM
Heather KiesslingAffiliateOct 16 '26Proposed Sale2.2021,83047,975Oct 16 05:23 PM
Ainscow RobertOFFICEROct 14 '26Proposed Sale2.0722,50046,575Oct 14 09:50 PM
Ryan Robert John AndrewDirectorSep 30 '26Buy2.6815,00040,200675,222Oct 01 05:52 PM
Ryan Robert John AndrewDirectorSep 28 '26Buy2.708,00021,600660,222Sep 30 06:30 AM
Todd WiderDirectorSep 25 '26Proposed Sale2.95200,000590,000Sep 25 04:08 PM
Ainscow RobertCOOSep 08 '26Sale4.298,43836,2162,248,441Sep 10 09:45 PM
Ainscow Donald GeorgeEVP, Gen Counsel, SecretarySep 02 '26Sale3.8923,67892,107776,322Sep 04 09:33 PM
Ainscow RobertCOOSep 02 '26Sale3.9025,00097,6252,256,879Sep 04 09:32 PM
Mann Paul ElliotChairman and CEOSep 04 '26Sale4.1083,759343,4129,328,570Sep 04 09:30 PM
Mann Paul ElliotChairman and CEOSep 03 '26Sale3.9283,758328,3319,412,329Sep 04 09:30 PM
Mann Paul ElliotChairman and CEOSep 02 '26Sale3.9183,758327,4949,496,087Sep 04 09:30 PM
Mann Paul ElliotDIRECTORSep 02 '26Proposed Sale3.7883,758316,605Sep 02 09:30 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 689.41B
IWMiShares Russell 2000 Index FundAUM: 78.30B
VXFVanguard Extended Market Index ETFAUM: 30.61B
MGNRAmerican Beacon GLG Natural Resources ETFAUM: 1.25B
IWOiShares Russell 2000 Growth ETFAUM: 14.20B
VTWOVanguard Russell 2000 Index ETFAUM: 16.97B
NUKZRange Nuclear Renaissance Index ETFAUM: 591.37M
SCHASchwab U.S. Small-Cap ETFAUM: 22.32B
SRVRPacer Data & Infrastructure Real Estate ETFAUM: 286.10M
VAWVanguard Materials ETFAUM: 3.02B

News

latest 14 of 204
  • ASP Isotopes Inc. Announces that Renergen Limited's Virginia Gas Project has Achieved Stable Liquid Helium Production (GlobeNewswire)
  • Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa (GlobeNewswire) +6.76%
  • Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire) -11.11%
  • ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update (GlobeNewswire)
  • ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa (GlobeNewswire)
  • Loading…
  • ASP Isotopes Announces Quantum Leap Energy is Evaluating Metal Conversion Opportunities in Namibia (GlobeNewswire)
  • ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update (Business Wire) -5.85%
  • ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South Africa (GlobeNewswire)
  • ASP Isotopes to Participate in Citi's 2026 Natural Resources Conference (GlobeNewswire) -5.59%
  • ASP Isotopes Issues Letter to Shareholders (GlobeNewswire)
  • ASP Isotopes to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026 (GlobeNewswire) +12.43%
  • ASP Isotopes to Hold Capital Markets Day on September 8 (GlobeNewswire) -6.79%
  • ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&M Engineering Experiment Station to Advance Uranium Conversion Technology (GlobeNewswire) +9.51%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q12026-06-03-0.060-0.060-0.1504.434.431
2025Q42026-02-25-0.790-0.100-0.17016.692.031
2025Q32025-12-03-0.150-0.150-0.1454.904.902
2025Q22025-09-03-1.030-1.030-1.0281.201.201
2025Q12025-05-28-0.120-0.120-0.1221.101.051
2024Q42025-03-31-0.130-0.090-0.1301.201.201
2024Q32024-11-27-0.090-0.090-0.1181.101.101
2024Q22024-08-28-0.240--0.2381.00--
2026Q2---0.170--4.471
2026Q3---0.150--7.341
2026Q4---0.090--16.631
2027Q1---0.080--18.501
2027Q2---0.080--20.221
2027Q3---0.080--23.131
2027Q4---0.080--25.861
2028Q1---0.600--42.401

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2023FY-0.490-0.480-0.4930.400.00
2024FY-0.630-0.570-0.6314.144.10
2025FY-2.110-1.320-1.00023.838.00
2026FY--0.470--32.86
2027FY--0.320--87.71
2028FY--0.875--257.37
2029FY--0.500--550
2030FY-0.530--721.12

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q2S2026-08-163004.471.506.50
2026Q2S2026-06-243014.471.506.50
2026Q2S2026-06-033034.471.506.50
2026Q2S2026-06-023034.471.506.50
2026Q2S2026-04-133035.273.906.50
2026Q2S2026-04-102025.955.406.50
2026Q2S2026-04-062008.057.009.10
2026Q2S2026-03-282008.057.009.11
2026Q2S2026-03-062108.057.009.11
2026Q2S2026-03-041107.007.007.00
2026Q2S2026-03-012108.907.0010.80
2026Q2S2026-02-253108.977.0010.80
2026Q2S2026-02-033108.977.0010.80
2026Q2S2026-01-123118.977.0010.80

Estimate history

EPS, annual-0.076-0.138-0.493-0.631-2.109-1.3167
Period20212022202320242025TTM
EPS, quarterly-0.238-0.118-0.13-0.122-1.028-0.145-0.841-0.057-0.274
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual000.4334.14423.84930.85
Period20212022202320242025TTM
Sales, quarterly1.0221.0881.1941.1021.1984.8916.664.185.123
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual34.35735.90748.92372.068111.678130.149
Period20212022202320242025MRQ
Shares, quarterly52.13368.40972.06872.06883.90593.377111.678125.903130.149
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Total Revenue30.8523.854.140.430.000.00
Cost of Goods Sold Incl. D&A31.0022.362.540.290.070.02
Gross Profit-0.151.491.600.14-0.07-0.02
Selling, General and Administrative Excl. Other96.2058.6827.9516.185.032.59
Research and Development22.0412.363.140.761.270.04
Other Operating Expense0.000.000.000.000.000.00
Operating Income-96.35-57.19-26.35-16.04-5.10-2.61
Interest Expense3.910.570.260.12--
Unusual Expense46.68108.627.010.19-0.150.00
Net Income Before Taxes-136.79-159.56-32.31-16.30-4.95-2.61
Income Taxes0.130.280.11-0.010.000.00
Consolidated Net Income-136.92-159.84-32.42-16.29-4.95-2.61
Net Income From Continuing Operations-151.63-175.09-32.33-16.29-4.95-2.61
Net Income-132.05-175.09-35.11-16.29-4.95-2.61
EPS (Recurring)-0.81-1.19-0.54-0.49-0.14-0.08
EPS (Basic, Before Extraordinaries)-1.32-2.11-0.63-0.49-0.14-0.08
EPS (Diluted)-1.32-2.11-0.63-0.49-0.14-0.08
EBITDA-90.55-55.28-25.88-16.00-5.03-2.59
Non-Operating Income (Expense)10.156.831.310.050.000.00
Other After Tax Adjustments0.000.000.000.000.000.00
Stock Option Compensation Expense14.7412.666.766.912.000.51
Price To Sales Ratio24.7418.6260.85136.69--
Gross Margin-0.496.2638.6032.09--
Operating Margin-312.31-239.80-635.91-3,704.63--
Net Margin-428.00-734.17-847.28-3,761.03--
Shares Outstanding130.15111.6872.0748.9235.9134.36
Market Capitalization303.55303.55323.4052.6446.4646.46

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue5.124.1816.664.891.201.101.191.09
Cost of Goods Sold Incl. D&A4.845.5715.515.070.630.770.590.79
Gross Profit0.28-1.391.15-0.190.570.330.610.29
Selling, General and Administrative Excl. Other34.4723.5023.4514.7812.548.288.255.73
Research and Development6.825.266.853.100.881.531.421.03
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-34.20-24.89-22.30-14.97-11.97-7.95-7.65-5.43
Interest Expense1.771.730.260.150.080.090.090.09
Unusual Expense3.46-0.5643.88-0.1063.900.942.112.31
Net Income Before Taxes-34.09-26.74-63.15-12.82-75.06-8.53-9.07-7.36
Income Taxes-0.10-0.030.180.070.10-0.070.15-0.01
Consolidated Net Income-33.99-26.71-63.33-12.89-75.16-8.46-9.22-7.36
Net Income From Continuing Operations-33.59-26.46-78.71-12.87-75.06-8.45-9.18-7.27
Net Income-33.59-6.88-78.71-12.87-75.06-8.45-9.18-7.27
EPS (Recurring)-0.25-0.06-0.51-0.15-0.42-0.11-0.11-0.09
EPS (Basic, Before Extraordinaries)-0.27-0.06-0.84-0.15-1.03-0.12-0.13-0.12
EPS (Diluted)-0.27-0.06-0.84-0.15-1.03-0.12-0.13-0.12
EBITDA-32.99-21.83-21.37-14.36-11.44-7.80-7.60-5.26
Non-Operating Income (Expense)5.34-0.683.302.190.890.450.780.47
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.593.494.123.543.501.491.791.63
Price To Sales Ratio24.7419.8621.00101.61117.2973.9777.2650.56
Gross Margin5.43-33.286.88-3.7947.7429.6750.7427.03
Operating Margin-667.48-595.41-133.88-306.10-998.76-721.89-640.58-499.55
Net Margin-655.57-164.55-472.46-263.30-6,263.88-766.72-769.03-668.50
Shares Outstanding130.15125.90111.6893.3883.9172.0772.0768.41
Market Capitalization303.55552.99592.99884.20617.32334.82323.40185.39

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY
Cash & Short Term Investments333.3161.897.912.392.95
Short Term Receivables51.710.730.940.000.00
Inventories8.490.070.000.000.00
Other Current Assets4.623.051.660.910.27
Total Current Assets398.1465.7410.513.303.22
Net Property, Plant & Equipment34.9623.4811.979.053.92
Total Investments and Advances47.310.000.000.000.00
Long-Term Note Receivable1.69----
Intangible Assets10.053.173.27-0.00
Deferred Tax Assets14.865.772.65--
Other Assets5.871.931.790.140.00
Total Assets512.88100.0930.1912.507.14
Short Term Debt Incl. Current Port. of LT Debt13.641.620.870.080.08
Accounts Payable5.751.020.000.000.06
Other Current Liabilities13.304.414.811.860.16
Total Current Liabilities32.707.065.671.940.30
Long Term Debt202.3236.121.270.740.84
Provision for Risks Charges0.000.000.000.000.00
Deferred Tax Liabilities14.965.742.76--
Other Liabilities0.000.001.650.000.00
Total Liabilities249.9848.9211.362.681.14
Non-Equity Reserves0.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00
Common Equity204.1547.9016.309.826.00
Total Shareholders Equity204.1547.9016.309.826.00
Accumulated Minority Interest58.753.272.530.000.00
Total Equity262.9051.1718.839.826.00
Total Liabilities & Stockholders Equity512.88100.0930.1912.507.14
Book Value Per Share1.830.660.330.270.17
Tangible Book Value Per Share1.740.620.270.270.17
Full-Time Employees271136764-
Price to Book Ratio0.978.017.958.598.59
Return on Assets-57.13-49.64-76.31-50.36-
Return on Equity-138.93-100.74-124.73-62.54-
Return on Invested Capital-43.08-38.48-92.70-46.83-38.13
Quick Ratio11.929.311.851.7110.62
Current Ratio12.189.311.851.7110.62

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Net Income-117.34-159.84-32.42-16.29-4.95-2.61
Depreciation5.491.910.470.040.070.02
Other Funds (Non Cash)48.26123.8318.029.671.902.25
Funds from Operations-63.83-34.15-14.07-6.57-2.97-0.34
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-3.98-3.63-2.621.160.03-0.24
Cash from Operating Activities-67.80-37.78-16.70-5.41-2.94-0.58
Capital Expenditures-15.77-9.65-11.37-2.33-4.47-2.99
Net Assets From Acquisitions9.494.570.00-0.120.000.00
Sale of Fixed Assets and Businesses20.9220.800.920.000.000.00
Purchase or Sale of Investments-77.36-75.740.000.000.000.00
Purchase of Investments-125.23-75.740.000.000.000.00
Sale Or Maturity of Investments47.870.000.000.000.000.00
Other Uses-50.70-30.000.000.000.000.00
Other Sources0.300.030.000.000.000.00
Cash from Investing Activities-113.12-90.00-10.45-2.45-4.47-2.99
Cash Dividends Paid0.000.000.000.000.000.00
Change in Capital Stock255.55307.0955.2814.096.656.45
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock255.55307.0955.2814.096.656.45
Proceedsfrom Stock Options255.41302.1749.4414.096.656.45
Issuance or Reduction of Debt, Net41.1644.1125.72-0.71-0.010.05
Change in Long Term Debt38.5941.5425.720.000.000.00
Issuance of Long Term Debt57.6857.6826.440.000.000.00
Reduction of Long Term Debt-19.10-16.14-0.710.000.000.00
Net Financing Active Other Cash Flow43.98-0.400.610.000.000.00
Other Financing Activities Uses-1.90-0.40-0.100.000.000.00
Cash from Financing Activities340.69350.8081.6113.396.646.50
Exchange Rate Effect-2.000.65-0.48-0.000.210.02
Net Change in Cash157.77223.6753.985.52-0.562.95
Free Cash Flow-83.58-47.43-28.07-7.74-7.41-3.57
Preferred Dividends (Cash Flow)-0.00-0.000.000.00
Deferred Taxes & Investment Tax Credit--0.04-0.140.020.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments259.02293.28333.31113.9467.6855.97
Short Term Receivables4.594.5951.7150.1331.030.69
Inventories1.531.378.491.371.050.34
Other Current Assets6.376.544.628.421.832.03
Total Current Assets271.50305.78398.14173.87101.5959.03
Net Property, Plant & Equipment240.69224.8834.9631.9028.6226.41
Total Investments and Advances45.9742.0747.316.320.000.00
Intangible Assets7.107.0710.058.043.363.26
Deferred Tax Assets-0.0714.860.070.030.11
Other Assets2.743.895.874.251.942.06
Total Assets572.05587.67512.88225.89135.9190.87
Short Term Debt Incl. Current Port. of LT Debt55.6154.2213.6413.040.991.49
Accounts Payable5.706.875.753.422.602.05
Other Current Liabilities8.979.2813.3011.863.314.65
Total Current Liabilities70.2870.3732.7028.326.908.18
Long Term Debt213.93207.62202.32100.62100.7036.96
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities8.015.9814.960.31--
Other Liabilities5.034.690.000.030.000.00
Total Liabilities297.26288.65249.98129.29107.6045.15
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity264.69289.00204.1574.0725.2342.51
Total Shareholders Equity264.69289.00204.1574.0725.2342.51
Accumulated Minority Interest10.1010.0258.7522.543.083.21
Total Equity274.79299.02262.9096.6028.3145.73
Total Liabilities & Stockholders Equity572.05587.67512.88225.89135.9190.87
Book Value Per Share2.032.301.830.790.300.59
Tangible Book Value Per Share1.982.241.740.710.260.54
Full-Time Employees--271---
Price to Book Ratio0.975.576.7431.9912.487.06
Return on Assets-42.84-56.92-57.13-68.10-104.85-49.66
Return on Equity-104.60-116.50-138.93-187.23-551.61-127.59
Return on Invested Capital-7.02-1.38-19.36-7.37-59.61-10.63
Quick Ratio3.844.3311.926.0914.567.17
Current Ratio3.864.3512.186.1414.727.21

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-33.99-7.12-63.33-12.89-75.16-8.46
Depreciation1.203.060.940.300.530.15
Other Funds (Non Cash)3.63-7.4748.393.7268.453.27
Funds from Operations-29.28-11.61-14.08-8.85-6.10-5.12
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital5.95-6.15-3.77-0.01-1.801.95
Cash from Operating Activities-23.33-17.76-17.85-8.86-7.90-3.17
Capital Expenditures-4.09-6.14-2.40-3.15-1.75-2.36
Net Assets From Acquisitions0.004.92-2.076.640.000.00
Sale of Fixed Assets and Businesses0.120.0020.800.000.000.00
Purchase or Sale of Investments8.38-10.00-70.74-5.000.000.00
Purchase of Investments-39.49-10.00-70.74-5.000.000.00
Sale Or Maturity of Investments47.870.000.000.000.000.00
Other Uses35.42-86.120.000.00-30.000.00
Other Sources0.120.160.030.000.000.00
Cash from Investing Activities39.95-97.18-54.38-1.50-31.75-2.36
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.41-0.27199.1156.3151.680.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.41-0.27199.1156.3151.680.00
Proceedsfrom Stock Options0.27-0.27199.1056.3146.760.00
Issuance or Reduction of Debt, Net-1.96-1.8144.800.13-0.60-0.22
Change in Long Term Debt-1.96-1.8142.230.13-0.60-0.22
Issuance of Long Term Debt0.000.0554.872.760.000.05
Reduction of Long Term Debt-1.96-1.87-12.65-2.63-0.60-0.26
Net Financing Active Other Cash Flow-0.9445.25-0.590.27-0.07-0.01
Other Financing Activities Uses-0.94-0.640.00-0.32-0.04-0.04
Cash from Financing Activities-2.5043.17243.3256.7051.01-0.23
Exchange Rate Effect-0.42-2.040.54-0.080.36-0.17
Net Change in Cash13.71-73.82171.6246.2611.71-5.92
Free Cash Flow-27.42-23.90-20.25-12.01-9.65-5.53

Revenue breakdown

Collaboration2024: 200.00K
Construction2025: 18.18M
Product2024: 3.94M 2025: 5.67M
Hong Kong2025: 18.18M
South Africa2024: 4.14M 2025: 4.82M
United States2025: 852.00K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3022.93%31.4M136.8M4.08M
2026-10-1521.23%29.0M136.8M4.17M
2026-09-3019.33%26.5M136.9M3.93M
2026-09-1519.05%26.1M136.9M3.91M
2026-08-3119.17%25.5M132.9M4.23M
2026-08-1420.15%26.8M132.9M4.81M
2026-07-3124.41%26.6M109.2M4.99M
2026-07-1522.21%24.2M109.2M4.90M
2026-06-3021.77%23.8M109.2M5.00M
2026-06-1521.21%23.1M108.9M5.07M
2026-05-2920.74%22.6M108.9M5.03M
2026-05-1520.44%23.1M113.0M4.46M
2026-04-3022.10%24.9M112.9M4.55M
2026-04-1522.44%25.3M112.9M5.08M
2026-03-3122.79%25.5M111.8M5.44M
2026-03-1320.07%22.4M111.8M5.40M
2026-02-2721.76%24.3M111.8M5.39M
2026-02-1320.27%22.7M111.8M6.05M
2026-01-3018.67%20.6M110.3M6.37M
2026-01-1519.24%21.2M110.3M6.81M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.501.251.601.6216.8905992.000.951-0.0580.000
call1.000.901.251.0213.54948.006.000.887-0.0590.000
call1.500.250.750.577.9159.005.000.791-0.0500.001
call2.000.050.150.172.2854783.000.518-0.0270.001
call2.500.000.050.052.7891421.000.205-0.0240.000
call3.000.000.200.054.00412.000.000.158-0.0300.000
call3.500.000.200.104.9291580.000.137-0.0330.000
call4.000.000.050.054.44132.000.000.125-0.0260.000
call4.500.000.050.004.9970.000.000.115-0.0280.000
call5.000.000.050.015.4761.000.000.108-0.0290.000
call5.500.000.200.007.3380.000.000.104-0.0410.000
put0.500.000.200.0018.6170.000.00-0.049-0.0580.000
put1.000.000.200.0010.0910.000.00-0.113-0.0590.000
put1.500.000.200.025.6051.000.00-0.209-0.0500.001
put2.000.050.150.062.0063170.00-0.482-0.0260.001
put2.500.450.750.475.7112535.00-0.795-0.0240.000
put3.000.801.251.027.1878.001.00-0.842-0.0300.000
put3.501.401.751.468.3022.001.00-0.863-0.0330.000
put4.001.902.251.959.1980.000.00-0.876-0.0350.000
put4.502.252.752.469.9483.001.00-0.884-0.0370.000
put5.002.803.302.9611.3941.001.00-0.891-0.0390.000
put5.503.403.803.5711.9640.000.00-0.896-0.0400.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-06425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-11-05425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-26425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-268-KCurrent report2026-10-26SEC
2026-10-214Statement of changes in beneficial ownership of securities2026-10-16SEC
2026-10-16144Filing for proposed sale of securities under Rule 144.SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-158-KCurrent report2026-10-15SEC
2026-10-14144Filing for proposed sale of securities under Rule 144.SEC
2026-10-083Initial statement of beneficial ownership of securities2026-10-01SEC
2026-10-08SCHEDULE 13DSEC
2026-10-028-KCurrent report2026-10-02SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-25144Filing for proposed sale of securities under Rule 144.SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-08SEC
2026-09-09425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-09-09425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-09-088-KCurrent report2026-09-08SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-08-21425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-08-208-KCurrent report2026-08-14SEC
2026-08-20425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-08-208-KCurrent report2026-08-20SEC
2026-08-188-KCurrent report2026-08-18SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100095.37K2
2026-0961.80K21.23M6
2026-080000
2026-0700145.22K1
2026-06003.48M8
2026-050000
2026-0400304.38K3
2026-0300158.67K2
2026-020000
2026-010000
2025-12001.45M3
2025-11001.78M4

Institutional holders

Manager% owned
BlackRock, Inc.7.32%
Encompass Capital Advisors LLC5.21%
UBS Group AG4.12%
VANGUARD CAPITAL MANAGEMENT LLC3.96%
Rovida Investment Management Ltd3.26%
GEODE CAPITAL MANAGEMENT, LLC2.40%
Alyeska Investment Group, L.P.2.26%
STATE STREET CORP2.06%
AWM Investment Company, Inc.1.26%
BNP Paribas Asset Management Holding S.A.1.25%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.85%
iShares Russell 2000 ETF2.42%
Range Nuclear Renaissance Index ETF1.41%
Fidelity Small Cap Index Fund1.01%
VANGUARD EXTENDED MARKET INDEX FUND1.00%
iShares Russell 2000 Growth ETF0.72%
American Beacon GLG Natural Resources ETF0.67%
Pacer Data & Infrastructure Real Estate ETF0.59%
VANGUARD RUSSELL 2000 INDEX FUND0.44%
Fidelity Extended Market Index Fund0.37%

OakChart. ASPI. Cached 15 minutes.